KOPN 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-11

• R&D revenues increased in the three and six months ended June 27, 2026 as compared to the three and six months ended June 28, 2025 primarily due to the Company’s progress on the Phase 2 Off-the-Visor Heads-Up Display program with the U.S. Army and due to the start of the development program with Fab…

• Cost of product revenues as a % of net product revenues 86% 94% 93% 88%

• The decrease in cost of product revenues as a percentage of net product revenues for the three months ended June 27, 2026, compared to the three months ended June 28, 2025, was primarily attributable to product mix. Cost of product revenues as a percentage of net product revenues increased during th…

• Research and Development. R&D expenses are incurred in support of internal display development programs and programs funded by agencies or prime contractors of the U.S. Government and commercial partners. R&D costs include staffing, purchases of materials and laboratory supplies, circuit design cost…

• Funded R&D expense for the three and six months ended June 27, 2026 increased as compared to the three and six months ended June 28, 2025 primarily due to the Company’s government grant for the development of ultra-bright, full color MicroLED displays optimized for ground soldier augmented reality a…

相对上期删除的文字 · 来源:10-Q · 2026-05-12

• R&D revenues increased slightly in the three months ended March 28, 2026 as compared to the three months ended March 29, 2025 primarily due to the timing of both starts of new programs and completion of our existing programs. This variance falls within the normal ebb and flow of funded programs. The…

• (In thousands, except for percentages) March 28, 2026 March 29, 2025

• Cost of product revenues as a % of net product revenues 103% 83%

• The increase in cost of product revenues as a percentage of net product revenues for the three months ended March 28, 2026, compared to the three months ended March 29, 2025, was primarily attributable to reduced production efficiency and lower production volume. The Company believes the negative 3%…

• Research and Development. R&D expenses are incurred in support of internal display development programs and programs funded by agencies or prime contractors of the U.S. Government and commercial partners. R&D costs include staffing, purchases of materials and laboratory supplies, circuit design cost…

相对上期新增的文字 · 来源:10-Q · 2026-08-11

• On June 25, 2026, BlueRadios, Inc. filed its opening and response appellate brief in the Federal Circuit, requesting that the court affirm the September 2025 judgment against Kopin Corporation for trade secret misappropriation and reverse portions of the district court's decision that denied additio…

相对上期新增的文字 · 来源:10-Q · 2026-08-11

• During the quarter ended June 27, 2026, Paul C. Baker, our Chief Operating Officer, terminated a Rule 10b5-1 trading arrangement on May 8, 2026. Mr. Baker had adopted this Rule 10b5-1 trading arrangement on November 18, 2025, pursuant to which he was permitted to sell up to 170,989 shares of the Com…

• During the quarter ended June 27, 2026, a Rule 10b5-1 trading arrangement of Michael Murray, our Chairperson, Chief Executive Officer, and President, terminated pursuant to its original terms a Rule 10b5-1 trading arrangement on April 17, 2026. Mr. Murray had adopted this Rule 10b5-1 trading arrange…

• During the quarter ended June 27, 2026, the following adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies on insider trading:

• Name & Title Date Adopted(1) Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement Expiration Date(2)

• (1) Date of adoption of Rule 10b5-1 trading arrangements is in accordance with both the Company’s insider trading policy and applicable SEC rules and regulations.

相对上期删除的文字 · 来源:10-Q · 2026-05-12

• During the quarter ended March 28, 2026, none of the Company’s directors or officers informed the Company of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (each as defined in Item 408(a) of Regulation S-K).